The largest database of trusted experimental protocols

B 27 supplement minus insulin

Manufactured by Thermo Fisher Scientific
Sourced in United States

B-27 supplement minus insulin is a cell culture supplement designed to support the growth and differentiation of neuronal cells in vitro. It contains a defined mixture of vitamins, hormones, and other components that promote the survival and maturation of neuronal cultures, without the inclusion of insulin.

Automatically generated - may contain errors

16 protocols using b 27 supplement minus insulin

1

Monolayer Cardiac Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monolayer cardiac differentiation was carried out following a published protocol59 (link). Briefly, RPMI 1640 media (Corning, 10040CVR) was used as the basal medium in the entire differentiation process. B-27 Supplement minus Insulin (Gibco, A1895601) was supplemented to the medium for the first 6 days and B-27 Supplement (Gibco, 17504044) was used afterwards. The small molecule inhibitor of GSK3β signaling, CHIR99021 (Selleckchem, S292425MG) was used in the first two days of differentiation and Wnt signaling inhibitor C59 (Selleckchem, S70375MG) was added from day 3 to day 4. To differentiate atrial cells, 1 uM retinoic acid (Sigma-Aldrich, R2625) was added from day 3 to day 6 as described Previously42 .
+ Open protocol
+ Expand
2

Directed Differentiation of iPSCs into Cardiomyocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The iPSC-CMs were generated using a 2D monolayer differentiation protocol as previously described [19 (link), 20 (link)]. Briefly, the iPSCs were dissociated and replated into matrigel-coated 6-well plates. Cells were cultured and expanded to 85% confluence and subsequently treated for 2 days with 6 μM CHIR99021 (Axon Medchem) in RPMI 1640 (Gibco) with B27 supplement minus insulin (Gibco) (RPMI + B27-Insulin) to activate Wnt signaling pathway. On day 2, cells were placed in RPMI + B27-Insulin with CHIR99021 removal. On days 3–4, cells were treated with 5 μM IWR-1 (Millipore) to inhibit Wnt signaling pathway. On days 5–6, cells were removed from IWR-1 treatment and placed in RPMI + B27-Insulin. From day 7 onwards, cells were placed and cultured in RPMI 1640 and B27 supplement with insulin (Gibco) (RPMI + B27 + Insulin) until beating foci were observed. Cells were glucose-starved for 3 days with RPMI + B27 + Insulin for purification. Cardiomyocytes of day 30–40 after cardiac differentiation were utilized for downstream functional assays.
+ Open protocol
+ Expand
3

Trilineage Differentiation of iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Passage number 21 iPSCs were used for trilineage differentiation. According to the manufacturer’s instructions, the iPSCs were induced toward ectoderm with the Human Pluripotent Stem Cell Functional Identification Kit (R&D Systems #SC027B). Endoderm was induced with the StemDiff Definitive Endoderm Differentiation Kit (STEMCELL Technologies #05110). Mesoderm was induced with the addition of 6 μM CHIR (Selleck Chemicals #S2924) dissolved in RPMI media supplemented with B27 supplement Minus Insulin (Gibco #11875–085 and #A18956–01) for 48 hr.
+ Open protocol
+ Expand
4

Hepatic Organoid Culturing and Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hep-Orgs used in this study were previously generated from human fetal livers that were obtained from Leiden University Medical Centre (MC) under the approval of the Dutch Ethical Medical Council (Leiden University MC) (Hu et al., 2018 (link); Artegiani et al., 2020 (link)). All organoids were grown in Cultrex reduced growth factor basement membrane extract (BME), type 2 (#3533-001; R&D Systems). Culturing medium was refreshed every 2 to 3 days, and organoids were split 1:6 or 1:8 every 7 days as previously described for Chol-Orgs (Broutier et al., 2016 (link)) and Hep-Orgs (Hu et al., 2018 (link)). Expansion culture medium components are listed in Table S1. Differentiation medium was prepared by adding 1 µM dexamethasone (#D4902; Sigma-Aldrich) and 10 ng/μl oncostatin M (#295-OM; R&D Systems) to Hep-Org expansion medium as described previously (Hu et al., 2018 (link)). In experiments testing the effect of insulin, insulin (#I9278; Sigma-Aldrich) was added for 1 day to Hep-Org expansion medium with a final concentration of 20 µg/ml, and medium without insulin was added for 7 days and was made by replacing the B-27 Supplement minus vitamin A of the expansion medium by B-27 Supplement minus insulin (#A1895601; Gibco). Since B-27 Supplement minus insulin contains vitamin A, B-27 Supplement (#17504044; Gibco) was used as a control in these experiments.
+ Open protocol
+ Expand
5

Optimized Stem Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagle medium (DMEM)/F12, glucose-free DMEM, Roswell Park Memorial Institute (RPMI) 1640 medium, fetal bovine serum (FBS), penicillin/streptomycin, collagenase type IV, dispase, accutase, B27 supplement, B27 supplement minus insulin, and 0.05% trypsin-ethylenediaminetetraacetic acid (trypsin-EDTA) were purchased from Thermo Fisher Scientific (Waltham, MA, United States). The mTeSR1 and mTeSR1 5× supplements were purchased from STEMCELL Technologies Inc. (Vancouver, BC, Canada). Human embryonic stem cell line H9 (WA09) was procured from WiCell Research Institute (Madison, WI, United States). Matrigel (#354277) was supplied by Corning Life Sciences (Tewksbury, MA, United States). Mitomycin C, gelatin, Y27632, CQ phosphate, AZM, and all other unlisted reagents were acquired from Sigma-Aldrich (St. Louis, MO, United States).
+ Open protocol
+ Expand
6

Feeder-free hiPSC Cardiomyocyte Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Feeder-free hiPSCs (iPS-DF19-9-7T and iPS-DF6-9-9T, WiCell) were cultured on hESC-qualified matrigel (Corning) with StemMACS iPSC-Brew XF media (Miltenyi Biotec). Conditions to differentiate hiPSCs into CMs in this work were tested against an established WNT-based cardiogenesis protocol (Lian et al., 2012 (link), 2013 (link)). Briefly, confluent hiPSCs were differentiated in RPMI 1640 media supplemented with B-27 supplement minus insulin (ThermoFisher Scientific) from days 0–7. To promote cardiogenesis, RPMI media was supplemented with 6 μM GSK3 inhibitor CHIR99021 (Tocris), and 5 μM WNT inhibitor IWR1 (Tocris) from differentiation days 0–2 and 3–5, respectively. Small molecule Nodal inhibitor SB431542 (Tocris) was added either at days 0–2, 3–5 or 5–7 as specified in the results section.
+ Open protocol
+ Expand
7

Feeder-free hiPSC Cardiomyocyte Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Feeder-free hiPSCs (iPS-DF19-9-7T and iPS-DF6-9-9T, WiCell) were cultured on hESC-qualified matrigel (Corning) with StemMACS iPSC-Brew XF media (Miltenyi Biotec). Conditions to differentiate hiPSCs into CMs in this work were tested against an established WNT-based cardiogenesis protocol (Lian et al., 2012 (link), 2013 (link)). Briefly, confluent hiPSCs were differentiated in RPMI 1640 media supplemented with B-27 supplement minus insulin (ThermoFisher Scientific) from days 0–7. To promote cardiogenesis, RPMI media was supplemented with 6 μM GSK3 inhibitor CHIR99021 (Tocris), and 5 μM WNT inhibitor IWR1 (Tocris) from differentiation days 0–2 and 3–5, respectively. Small molecule Nodal inhibitor SB431542 (Tocris) was added either at days 0–2, 3–5 or 5–7 as specified in the results section.
+ Open protocol
+ Expand
8

Cardiomyocyte Differentiation from hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
In this study, human induced pluripotent stem cells (hiPSC) expressing GCaMP (kindly gifted by Prof. Bruce Conklin, Gladstone Institute, USA) were cultured on Matrigel coated plates with mTeSR‐1 medium (StemCell Technologies). hiPSC were passaged by using 0.5 × 10−3m ethylenediaminetetraacetic acid (Gibco) every 4–5 days. Differentiation of hiPSCs to cardiomyocytes was based on a previously described protocol.[68] Briefly, at 80–90% confluence, the medium was exchanged with a differentiation medium composed of RPMI‐1640, 2% B27 supplement minus insulin (ThermoFisher Scientific), 1% penicillin/streptomycin, and supplemented with 6 × 10−6m CHIR99021 (Stemgent) for 2 days. Medium was then exchanged into RPMI/B27 supplemented with 2 × 10−6m Wnt‐C59 (Selleck Chemicals) for another 2 days. After the 5th day, cells were cultured with RPMI/B27 medium alone. Cardiomyocytes (after 10–14 days of differentiation) were enzymatically dissociated using TrypLE express (Gibco). For bioprinting experiments, 8 million cardiomyocytes were suspended in 1 mL fibrin bioink.
+ Open protocol
+ Expand
9

Germ Layer Differentiation of iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Differentiation ability of iPSCs (P6) into the three germ layers was assessed by evaluating the expression of specific markers. Endoderm and ectoderm lineages were generated using the Human Pluripotent Stem Cell Functional Identification Kit (R&D Systems). For induction of mesoderm layers, cells were treated with 6 μM CHIR99021 (Selleck Chemicals) in RPMI 1640 media (Thermo Fisher Scientific) supplemented with B27 Supplement minus insulin (Thermo Fisher Scientific) for 2 days. Samples were then fixed and subjected to immunostaining using germ layer specific markers.
+ Open protocol
+ Expand
10

Verifying iPSC Differentiation Potential

Check if the same lab product or an alternative is used in the 5 most similar protocols
The differentiation potential of iPSCs (p46) was verified through cell differentiation into the three germ layers by measuring the expression of endoderm (OTX2, PAX6), mesoderm (Brachyury, TBX6), and ectoderm (SOX17, FOXA2) markers. Cells of endoderm and ectoderm lineages were generated using a Human Pluripotent Stem Cell Functional Identification Kit (R&D Systems). Cells of mesoderm layers were induced with 6 μM CHIR99021 (Selleck Chemicals) in RPMI 1640 media (Thermo Fischer Scientific) with B27 Supplement minus insulin (Thermo Fischer Scientific) for 2 days. Samples were fixed and stained for their respective markers.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!